| Bioactivity | BIM-23190, a somatostatin analog, a selective SSTR2 and SSTR5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly[1][3]. |
| Invitro | BIM-23190 tends to mildly stimulate PRL secretion[1]. |
| Name | BIM-23190 |
| CAS | 182153-96-4 |
| Sequence | {4-(2-Hydroxyethyl)-1-piperazinylacetyl}-{D-Phe}-Cys-Tyr-{D-Trp}-Lys-{Abu}-Cys-Thr-NH2 (Disulfide bridge: Cys2-Cys7) |
| Shortening | {4-(2-Hydroxyethyl)-1-piperazinylacetyl}-{D-Phe}-CY-{D-Trp}-K-{Abu}-CT-NH2 (Disulfide bridge: Cys2-Cys7) |
| Formula | C57H79N13O12S2 |
| Molar Mass | 1202.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
BIM-23190
CAS: 182153-96-4 F: C57H79N13O12S2 W: 1202.45
BIM-23190, a somatostatin analog, a selective SSTR2 and SSTR5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SST
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.